Harri Blåfield

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

Timo Möttönen, Pekka Hannonen, Marjatta Leirisalo‐Repo et al. · The Lancet · 1999 · 868 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease‐modifying antirheumatic drugs: Five‐year experience from the FIN‐RACo study

Markku Korpela, Leena Laasonen, Pekka Hannonen et al. · Arthritis & Rheumatism · 2004 · 277 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Impact of initial aggressive drug treatment with a combination of disease‐modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five‐year randomized followup trial

Kari Puolakka, Hannu Kautiainen, Timo Möttönen et al. · Arthritis & Rheumatism · 2004 · 179 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.

Heidi Mäkinen, Hannu Kautiainen, Pekka Hannonen et al. · PubMed · 2007 · 126 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial

Vappu Rantalaiho, Markku Korpela, Leena Laasonen et al. · Arthritis Research & Therapy · 2010 · 108 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12